Product Images Levonorgestrel And Ethinyl Estradiol And Ethinyl Estradiol

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Levonorgestrel And Ethinyl Estradiol And Ethinyl Estradiol NDC 0378-7316 by Mylan Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - 2bb5d4df 72a9 4f35 80c1 d3634327b14a 01

Figure 1 - 2bb5d4df 72a9 4f35 80c1 d3634327b14a 01

This appears to be a table showing the percentage of bleeding or spotting experienced at various points during a menstrual cycle. The cycles are divided into different lengths of time, and there are different percentages of bleeding or spotting for each cycle length. However, the output does not provide any additional context regarding what the data actually represents or what it is for.*

Figure - 2bb5d4df 72a9 4f35 80c1 d3634327b14a 04

Figure - 2bb5d4df 72a9 4f35 80c1 d3634327b14a 04

Not available. The text contains many misspelled and incomplete words, making it difficult to decipher.*

Structural Formula - image 01

Structural  Formula - image 01

Levonorgestrel is a medication used as a type of emergency contraception. CaMal is a term that is not recognizable or understandable. MW 3124 might be referring to the molecular weight of the compound which is 312.4 g/mol.*

image 02

image 02

This appears to be a chemical compound, specifically a combination of ethinyl and estradiol. The molecular weight of the compound is 2964.*

image 03

image 03

image 04

image 04

image 05

image 05

image 06

image 06

This appears to be a description of Levonorgestrel and Ethinyl Estradiol Tablets, USP and Ethinyl Estradiol Tablets. The tablets come in different dosages, as indicated in the text, and are intended to be dispensed by a pharmacist with a prescription. The blister cards should not be separated from the drug product, and each pouch contains one extended tablet or a pack of 91 tablets. Otherwise, the text is difficult to read due to errors.*

image 07

image 07

This is a collection of scientific studies that compared the risk of certain health outcomes between women who have ever used combined oral contraceptives (COC) and those who have never used them. The studies were conducted in different countries and have different outcomes measures such as odds ratios, hazard ratios, or relative risk ratios. The studies provide estimates of the effect and confidence intervals around those estimates. The last line seems to depict a range of numbers that are not related to the text and may be an error.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.